4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001628280-26-023949
Chief Scientific Officer sold 4,170 shares at $13.43 ($56,014)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lorrain Daniel S. Chief Scientific Officer | 2026-04-06 | Sale 10b5-1 | −4,170 | $13.43 | $56,014 | 147,712 | D |
| Open-market sales · 4,170 sh · avg $13.43 · $56,014 | |||||||
Loading xslF345X06/wk-form4_1775511809.xml…